Andrea Tan
Stock Analyst at Goldman Sachs
(1.65)
# 3,068
Out of 4,827 analysts
44
Total ratings
40.74%
Success rate
-7.09%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrea Tan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TARS Tarsus Pharmaceuticals | Maintains: Neutral | $46 → $51 | $47.56 | +7.23% | 4 | May 5, 2025 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $18 → $16 | $3.29 | +386.32% | 6 | Apr 17, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $39 → $27 | $6.86 | +293.59% | 6 | Mar 25, 2025 | |
| INSM Insmed | Maintains: Buy | $74 → $102 | $66.74 | +52.83% | 9 | Jul 10, 2024 | |
| SGMT Sagimet Biosciences | Maintains: Neutral | $23 → $6 | $3.36 | +78.57% | 5 | Jul 1, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Neutral | $31 | $13.27 | +133.61% | 1 | Jun 5, 2024 | |
| RLMD Relmada Therapeutics | Downgrades: Sell | $3 → $2 | $0.36 | +462.43% | 3 | Jun 5, 2024 | |
| KOD Kodiak Sciences | Reinstates: Sell | $2 | $4.17 | -52.04% | 1 | Dec 11, 2023 | |
| KRYS Krystal Biotech | Initiates: Buy | $160 | $141.26 | +13.27% | 1 | Nov 20, 2023 | |
| ABCL AbCellera Biologics | Maintains: Buy | $27 → $24 | $2.06 | +1,067.88% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $10 → $4 | $1.05 | +280.95% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $178 → $375 | $302.94 | +23.79% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $13 | $4.52 | +187.61% | 1 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6 → $4 | $0.16 | +2,336.05% | 2 | May 24, 2022 |
Tarsus Pharmaceuticals
May 5, 2025
Maintains: Neutral
Price Target: $46 → $51
Current: $47.56
Upside: +7.23%
Iovance Biotherapeutics
Apr 17, 2025
Maintains: Buy
Price Target: $18 → $16
Current: $3.29
Upside: +386.32%
Day One Biopharmaceuticals
Mar 25, 2025
Maintains: Buy
Price Target: $39 → $27
Current: $6.86
Upside: +293.59%
Insmed
Jul 10, 2024
Maintains: Buy
Price Target: $74 → $102
Current: $66.74
Upside: +52.83%
Sagimet Biosciences
Jul 1, 2024
Maintains: Neutral
Price Target: $23 → $6
Current: $3.36
Upside: +78.57%
Arrowhead Pharmaceuticals
Jun 5, 2024
Initiates: Neutral
Price Target: $31
Current: $13.27
Upside: +133.61%
Relmada Therapeutics
Jun 5, 2024
Downgrades: Sell
Price Target: $3 → $2
Current: $0.36
Upside: +462.43%
Kodiak Sciences
Dec 11, 2023
Reinstates: Sell
Price Target: $2
Current: $4.17
Upside: -52.04%
Krystal Biotech
Nov 20, 2023
Initiates: Buy
Price Target: $160
Current: $141.26
Upside: +13.27%
AbCellera Biologics
Aug 4, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $2.06
Upside: +1,067.88%
Jan 9, 2023
Maintains: Sell
Price Target: $10 → $4
Current: $1.05
Upside: +280.95%
Dec 20, 2022
Maintains: Buy
Price Target: $178 → $375
Current: $302.94
Upside: +23.79%
Dec 15, 2022
Initiates: Sell
Price Target: $13
Current: $4.52
Upside: +187.61%
May 24, 2022
Maintains: Neutral
Price Target: $6 → $4
Current: $0.16
Upside: +2,336.05%